Cardiac Device Procedures
Research activity is centered on pacemaker implantation in patients requiring ongoing anticoagulation, with attention to bleeding-related outcomes after device placement.
- Pacemaker implantation
- Anticoagulated patients
- Post-procedural haemorrhage
The clinical focus includes management of haematoma and other bleeding events in the setting of cardiac rhythm device care.
Haemostasis and Bleeding Control
The sponsor’s research interests include antihaemorrhagic strategies aimed at reducing bleeding complications associated with invasive cardiac procedures.
- Haemorrhage prevention
- Haematoma reduction
- Perioperative bleeding
These studies reflect a therapeutic emphasis on maintaining procedural safety in patients with elevated bleeding risk.
Anticoagulation Management
Clinical interest extends to patients treated with acenocoumarol, with evaluation of bleeding outcomes in the context of continued oral anticoagulant therapy.
- Acenocoumarol
- Oral anticoagulation
- Bleeding risk assessment
The sponsored trial activity is directed toward balancing anticoagulant treatment with procedural bleeding control.
Topical Tranexamic Acid
Research includes the use of tranexamic acid in a topical formulation to limit blood loss and local bleeding at the pacemaker implantation site.
- Tranexamic acid
- Topical application
- Local haemostatic effect
This area of interest lies at the intersection of procedural cardiology and targeted haemostatic support.
